Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
about
Pharmacological Targeting of the Hepcidin/Ferroportin AxisIroning out FerroportinThe global prevalence of HFE and non-HFE hemochromatosis estimated from analysis of next-generation sequencing data.Human macrophage ferroportin biology and the basis for the ferroportin disease.Ceruloplasmin-ferroportin system of iron traffic in vertebrates.Non-HFE hemochromatosisPolymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis.Novel gain of function mutation in the SLC40A1 gene associated with hereditary haemochromatosis type 4.EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH).Molecular diagnosis of hemochromatosis."Pumping iron"-how macrophages handle iron at the systemic, microenvironmental, and cellular levelsCryptogenic chronic hepatitis and its changing guise in adults.Molecular diagnostic and pathogenesis of hereditary hemochromatosis.The regulation of iron metabolism in the mononuclear phagocyte system.HFE-related hemochromatosis: an update for the rheumatologist.Iron overload and altered iron metabolism in ovarian cancer.Structure-function analysis of the human ferroportin iron exporter (SLC40A1): effect of hemochromatosis type 4 disease mutations and identification of critical residues.The role of genetic factors in patients with hepatocellular carcinoma and iron overload - a prospective series of 234 patients.Ferroportin-related haemochromatosis associated with novel Y64H mutation of the SCL40A1 gene.Type 4B hereditary hemochromatosis associated with a novel mutation in the SLC40A1 gene: A case report and a review of the literature.Pediatric Ferroportin Disease.Detection of a rare mutation in the ferroportin gene through targeted next generation sequencing.A novel mutation in the SLC40A1 gene associated with reduced iron export in vitro.Ferroportin disease: pathogenesis, diagnosis and treatment.Ferroportin diseases: functional studies, a link between genetic and clinical phenotype.The dynamics of hepcidin-ferroportin internalization and consequences of a novel ferroportin disease mutation.A convenient luminescence assay of ferroportin internalization to study its interaction with hepcidin.Hepcidin resistance in dysmetabolic iron overload.A structural model of human ferroportin and of its iron binding site.
P2860
Q26738350-B6167F77-0C5D-49BB-BBCB-96804D28885EQ28087429-1855989E-1AAA-4654-8367-C28826974D3EQ31030085-8D5D6EF1-5286-47E8-82AC-999E169331C6Q33628733-F7D05E9D-4E86-4DF9-9963-7363B0132FE8Q33728846-F6EE843C-4B47-4328-93F7-2A928D04A2A5Q34304892-1A40E5D3-AE5F-4BC5-8FF8-05624B8D8B92Q34375802-2C118ED1-B70E-47B9-A36A-354EC942ACB9Q34480045-C16F29FB-5E9F-4C9D-886F-CCBA8C77F29FQ34483947-05A74629-2B87-4796-8F07-AC1FD9A5EB5DQ34636616-269FD00D-972C-49CF-A914-FB2AEE52F1F1Q37716856-EECE5F22-FED1-4536-A3A2-724E222D6FD8Q37885803-579A49A2-4066-4DB2-8342-6E3ED54A640EQ37992618-D17258EC-889D-4375-A9C2-8ED401E6DFB8Q38132816-470A3107-52CF-4352-B6F5-0CDEF6FC1261Q38165094-4A08CA7C-866A-4893-9AE3-052D28E11C36Q39092091-237B2318-C827-49B0-AA8E-5353758DA4A0Q39137463-BF59C37C-8EEF-40C5-A9B9-60F40D592854Q41209458-892B8490-1D10-4571-AC16-2451A56296B8Q42020949-AAB66035-B448-465C-8441-6483AA14AB51Q42123916-6CCA0B1D-DE1B-4FF6-86B9-D88187F8C335Q42165317-8E484741-E248-4A06-AC9B-EBD98AF934DBQ42367931-200E6BF4-7588-4A4C-A542-0CC9734E4603Q45905043-2BAAD0D8-484A-434C-8EE8-4F7975F9883BQ47109362-A2C0CDCB-2F99-4D53-A1A3-736CB3E0FC1DQ47783604-014EE6C0-B89E-431D-9673-F22A10A373B9Q48168878-38A9953D-1F07-4B20-800B-70468D8186E9Q50483855-80F55011-646B-4A22-8730-7301CCB0E918Q53141858-648CB090-3496-4105-99D2-CDBD9E53ED0AQ54290351-61D21666-6C66-4223-BA88-0AFE6A6C0E38
P2860
Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
@ast
Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
@en
Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
@nl
type
label
Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
@ast
Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
@en
Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
@nl
prefLabel
Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
@ast
Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
@en
Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
@nl
P2093
P2860
P1476
Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
@en
P2093
Heinz Zoller
Melanie Schranz
Roman Mayr
William J H Griffiths
Wolfgang Vogel
P2860
P304
P356
10.1016/J.JHEP.2010.05.016
P577
2010-07-17T00:00:00Z